Cargando…
Two Pandemics, One Challenge—Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding
In many settings, the ongoing coronavirus disease (COVID-19) pandemic coincides with other major public health threats, in particular tuberculosis. Using tuberculosis (TB) molecular diagnostic infrastructure, which has substantially expanded worldwide in recent years, for COVID-19 case-finding might...
Autores principales: | Homolka, Susanne, Paulowski, Laura, Andres, Sönke, Hillemann, Doris, Jou, Ruwen, Günther, Gunar, Claassens, Mareli, Kuhns, Martin, Niemann, Stefan, Maurer, Florian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588527/ https://www.ncbi.nlm.nih.gov/pubmed/32956612 http://dx.doi.org/10.3201/eid2611.202602 |
Ejemplares similares
-
Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany
por: Sonnenkalb, Lindsay, et al.
Publicado: (2021) -
Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023) -
It’s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa
por: Skinner, Donald, et al.
Publicado: (2016) -
Smear Microscopy for Diagnosis of Pulmonary Tuberculosis in Eastern Sudan
por: Shuaib, Yassir A., et al.
Publicado: (2018) -
Sustainable Laboratory Capacity Building in Sierra Leone: From Ebola to COVID-19
por: Wang, Lili, et al.
Publicado: (2023)